Search Results

There are 16444 results for: content related to: Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulation

  1. You have free access to this content
    Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu

    International Journal of Cancer

    Volume 119, Issue 2, 15 July 2006, Pages: 441–454, Marie P. Piechocki, George H. Yoo, Susan K. Dibbley, Esmael H. Amjad and Fulvio Lonardo

    Version of Record online : 9 FEB 2006, DOI: 10.1002/ijc.21837

  2. VEGF inhibitor (Iressa) arrests histone deacetylase expression: Single-cell cotransfection imaging cytometry for multi-target-multi-drug analysis

    Journal of Cellular Physiology

    Volume 226, Issue 8, August 2011, Pages: 2115–2122, Yu Kyung Tak, Pravin K. Naoghare, Eunyoung Han and Joon Myong Song

    Version of Record online : 25 APR 2011, DOI: 10.1002/jcp.22540

  3. “Combi-targeting” mitozolomide: Conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer

    The Prostate

    Volume 72, Issue 12, 1 September 2012, Pages: 1273–1285, Youqiang Fang, Qiyu Qiu, Juozas Domarkas, Anne-Laure Larroque-Lombard, Suman Rao, Zakaria Rachid, Bernard F. Gibbs, Xin Gao and Bertrand J. Jean-Claude

    Version of Record online : 30 JAN 2012, DOI: 10.1002/pros.22475

  4. A 2,6-Disubstituted 4-Anilinoquinazoline Derivative Facilitates Cardiomyogenesis of Embryonic Stem Cells


    Volume 7, Issue 4, April 2012, Pages: 733–740, Guofang Shen, Ying Hu, Jianwei Wu, Ke Jin, Danyan Zhu, Yandong Zhang, Prof. Dr. Yongping Yu and Prof. Dr. Yijia Lou

    Version of Record online : 2 FEB 2012, DOI: 10.1002/cmdc.201100603

  5. You have free access to this content
    Insulin-induced proliferation of bladder cancer cells is mediated through activation of the epidermal growth factor system

    The FEBS Journal

    Volume 273, Issue 23, December 2006, Pages: 5479–5489, Dorthe Ornskov, Ebba Nexo and Boe S. Sorensen

    Version of Record online : 3 NOV 2006, DOI: 10.1111/j.1742-4658.2006.05539.x

  6. You have free access to this content
    Mutation of epidermal growth factor receptor is associated with MIG6 expression

    The FEBS Journal

    Volume 276, Issue 18, September 2009, Pages: 5239–5251, Takeshi Nagashima, Ryoko Ushikoshi-Nakayama, Atsushi Suenaga, Kaori Ide, Noriko Yumoto, Yoshimi Naruo, Kaoru Takahashi, Yuko Saeki, Makoto Taiji, Hiroshi Tanaka, Shih-Feng Tsai and Mariko Hatakeyama

    Version of Record online : 10 AUG 2009, DOI: 10.1111/j.1742-4658.2009.07220.x

  7. Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics

    Journal of Cellular Physiology

    Volume 212, Issue 3, September 2007, Pages: 710–716, Marco Rosetti, Wainer Zoli, Anna Tesei, Paola Ulivi, Francesco Fabbri, Ivan Vannini, Giovanni Brigliadori, Anna Maria Granato, Dino Amadori and Rosella Silvestrini

    Version of Record online : 25 APR 2007, DOI: 10.1002/jcp.21067

  8. Derivatives of Iressa, a Specific Epidermal Growth Factor Receptor Inhibitor, are Powerful Apoptosis Inducers in PC3 Prostatic Cancer Cells


    Volume 2, Issue 3, March 12, 2007, Pages: 318–332, Aurélie Telliez, Matthieu Desroses, Nicole Pommery, Olivier Briand, Amaury Farce, Guillaume Laconde, Amélie Lemoine, Patrick Depreux and Jean-Pierre Hénichart

    Version of Record online : 8 JAN 2007, DOI: 10.1002/cmdc.200600128

  9. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells

    Acta Pharmacologica Sinica

    Volume 28, Issue 8, August 2007, Pages: 1224–1230, Wei-guo HU, Tao LIU, Jiong-xin XIONG and Chun-you WANG

    Version of Record online : 31 JUL 2007, DOI: 10.1111/j.1745-7254.2007.00620.x

  10. EGFR Regulates the Side Population in Head and Neck Squamous Cell Carcinoma

    The Laryngoscope

    Volume 116, Issue 3, March 2006, Pages: 401–406, Jocelyn S. Chen, Francisco S. Pardo, Jessica Wang-Rodriguez, Theresa S. Chu, Jay Patrick Lopez, Joseph Aguilera, Xabier Altuna, Robert A. Weisman and Weg M. Ongkeko

    Version of Record online : 2 JAN 2009, DOI: 10.1097/01.mlg.0000195075.14093.fb

  11. You have free access to this content
    Gefitinib, a novel, orally administered agent for the treatment of cancer

    Journal of Clinical Pharmacy and Therapeutics

    Volume 29, Issue 2, April 2004, Pages: 95–103, M. Ranson and S. Wardell

    Version of Record online : 22 MAR 2004, DOI: 10.1111/j.1365-2710.2004.00543.x

  12. Tyrosine kinase inhibitors in endometrial cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue 2, March 2005, Pages: 409–411, K.K. Leslie, L. Laidler, L. Albitar, S. Davies, A. Holmes, T. Nguyen, J. Bolnick and D. Dai

    Version of Record online : 18 MAR 2005, DOI: 10.1111/j.1525-1438.2005.abst_20.x

  13. Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of 18F-Iressa and related molecular probes

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 48, Issue 11, 15 October 2005, Pages: 829–843, Yann Seimbille, Michael E. Phelps, Johannes Czernin and Daniel H. S. Silverman

    Version of Record online : 2 SEP 2005, DOI: 10.1002/jlcr.998

  14. Pharmacodynamic Assays in Cancer Drug Discovery: From Preclinical Validation to Clinical Trial Monitoring

    Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development

    Robert B. Lobell, Nancy E. Kohl, Laura Sepp-Lorenzino, Pages: 227–254, 2005

    Published Online : 28 JAN 2005, DOI: 10.1002/047165616X.ch11

  15. Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells


    Volume 7, Issue 14, No. 14 July 2007, Pages: 2384–2397, Yunhao Chen, Teck-Yew Low, Lee-Yee Choong, Rajarshi Sankar Ray, Yee-Ling Tan, Weiyi Toy, Qingsong Lin, Boon Keong Ang, Chee Hong Wong, Simin Lim, Bin Li, Choy-Leong Hew, Newman Siu-Kwan Sze, Brian J. Druker and Yoon-Pin Lim

    Version of Record online : 14 JUN 2007, DOI: 10.1002/pmic.200600968

  16. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  17. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Peter Tugwell and George A Wells

    Published Online : 17 NOV 2016, DOI: 10.1002/14651858.CD012437

  18. You have full text access to this Open Access content
    A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (“Iressa”

    Cancer Science

    Volume 94, Issue 5, May 2003, Pages: 453–458, Seiji Yano, Takanori Kanematsu, Toyokazu Miki, Yoshinori Aono, Masahiko Azuma, Akihiko Yamamoto, Hisanori Uehara and Saburo Sone

    Version of Record online : 19 AUG 2005, DOI: 10.1111/j.1349-7006.2003.tb01464.x

  19. You have free access to this content
    Neuraminidase inhibitors for preventing and treating influenza in adults and children

    Intervention Review

    The Cochrane Library

    Tom Jefferson, Mark A Jones, Peter Doshi, Chris B Del Mar, Rokuro Hama, Matthew J Thompson, Elizabeth A Spencer, Igho J Onakpoya, Kamal R Mahtani, David Nunan, Jeremy Howick and Carl J Heneghan

    Published Online : 10 APR 2014, DOI: 10.1002/14651858.CD008965.pub4

  20. You have free access to this content
    Appendix : Case Histories

    Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand

    Tony Ellery, Neal Hansen, Pages: 294–370, 2012

    Published Online : 8 MAY 2012, DOI: 10.1002/9781118266755.app1